戴维医疗
(300314)
| 流通市值：14.60亿 | | | 总市值：29.26亿 |
| 流通股本：1.44亿 | | | 总股本：2.88亿 |
| 利润表 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 营业总收入 | 112,797,919.57 | 584,030,132.77 | 392,655,821.72 | 251,256,793.39 |
| 营业总成本 | 106,008,569.07 | 506,371,105.43 | 330,449,667.87 | 206,184,417.31 |
| 其他经营收益 | | | | |
| 营业利润 | 11,582,859.93 | 98,648,091.1 | 82,770,666.46 | 58,487,731.01 |
| 利润总额 | 11,325,797.26 | 98,657,480.85 | 82,193,678.53 | 58,029,635.59 |
| 净利润 | 9,885,818.51 | 87,053,319.69 | 72,617,842.77 | 50,976,694.29 |
| 每股收益 | | | | |
| 其他综合收益 | -407,408.33 | 2,662,473.46 | 2,715,646.99 | 3,245,598.9 |
| 综合收益总额 | 9,478,410.18 | 89,715,793.15 | 75,333,489.76 | 54,222,293.19 |
| 资产负债表 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 流动资产: | | | | |
| 流动资产合计 | 901,669,079.49 | 934,681,736.29 | 879,256,716.39 | 895,432,978.42 |
| 非流动资产: | | | | |
| 非流动资产合计 | 548,861,873.02 | 557,086,394.21 | 564,359,409.94 | 525,328,814.3 |
| 资产总计 | 1,450,530,952.51 | 1,491,768,130.5 | 1,443,616,126.33 | 1,420,761,792.72 |
| 流动负债: | | | | |
| 流动负债合计 | 201,067,755.56 | 251,816,832.18 | 216,567,496.67 | 214,874,055.06 |
| 非流动负债: | | | | |
| 非流动负债合计 | 7,007,624.62 | 6,974,136.17 | 8,453,770.9 | 8,404,075.47 |
| 负债合计 | 208,075,380.18 | 258,790,968.35 | 225,021,267.57 | 223,278,130.53 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 1,242,455,572.33 | 1,232,977,162.15 | 1,218,594,858.76 | 1,197,483,662.19 |
| 股东权益合计 | 1,242,455,572.33 | 1,232,977,162.15 | 1,218,594,858.76 | 1,197,483,662.19 |
| 负债和股东权益合计 | 1,450,530,952.51 | 1,491,768,130.5 | 1,443,616,126.33 | 1,420,761,792.72 |
| 现金流量表 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 123,146,421.15 | 640,632,827.1 | 422,139,601.03 | 275,914,567.76 |
| 经营活动现金流出小计 | 160,605,530.26 | 551,383,091.62 | 407,335,362.63 | 279,898,461.66 |
| 经营活动产生的现金流量净额 | -37,459,109.11 | 89,249,735.48 | 14,804,238.4 | -3,983,893.9 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 196,881,085.64 | 1,191,720,777.87 | 943,424,144.47 | 660,188,862.68 |
| 投资活动现金流出小计 | 176,078,361.91 | 1,141,250,061.03 | 870,823,639.58 | 622,480,130.18 |
| 投资活动产生的现金流量净额 | 20,802,723.73 | 50,470,716.84 | 72,600,504.89 | 37,708,732.5 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | - | - | - | - |
| 筹资活动现金流出小计 | - | 28,498,474.08 | 26,777,237.04 | 10,225,643.64 |
| 筹资活动产生的现金流量净额 | - | -28,498,474.08 | -26,777,237.04 | -10,225,643.64 |
| 汇率变动对现金及现金等价物的影响 | -4,835,763.62 | -4,870,468.09 | -1,641,416.03 | 641,658.04 |
| 现金及现金等价物净增加额 | -21,492,149 | 106,351,510.15 | 58,986,090.22 | 24,140,853 |
| 期末现金及现金等价物余额 | 416,420,533.3 | 437,912,682.3 | 390,547,262.37 | 355,702,025.15 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | - | 106,351,510.15 | - | 24,140,853 |